ISO 16256:2012Withdrawn

Clinical laboratory testing and in vitro diagnostic test systems — Reference method for testing the in vitro activity of antimicrobial agents against yeast fungi involved in infectious diseases

Essais de laboratoire clinique et systèmes de diagnostic in vitro — Méthode de référence pour soumettre à essai l'activité in vitro des agents antimicrobiens par rapport aux levures impliquées dans les maladies infectieuses

This edition has been replaced by ISO 16256:2021.

Abstract / scope

ISO 16256:2012 describes a method for testing the susceptibility to antifungal agents of yeasts, including Candida spp. and Cryptococcus neoformans, that cause infections. The reference method described here has not been used in studies of the yeast forms of dimorphic fungi, such as B. dermatitidis and/or H. capsulatum variety capsulatum.

ISO 16256:2012 describes the broth microdilution reference method which can be implemented by either of two pathways. One pathway involves visual determination of MICs (CLSI method); the second pathway involves spectrophotometric determination of MICs (EUCAST method).

Life cycle

Replaced by

ISO 16256:2021PublishedClinical laboratory testing and in vitro diagnostic test systems — Broth micro-dilution reference method for testing the in vitro activity of antimicrobial agents against yeast fungi involved in infectious diseasesInternational Standard · Published 14 Oct 2021 · ISO/TC 212